Views & Analysis | Perspectives on pharma industry issues

Patients

Maintenance: The underexamined half of the GLP-1 story

GLP-1 treatments have historically had an exit problem, as appetite suppression stops when the medication stops.

Oncology

pharmaphorum podcast Episode 276, Irina Babina, Concr

Getting predictive technologies to patients, with Concr

Dr Irina Babina, CEO of oncology R&D platform Concr, discusses how current regulatory frameworks were built for static diagnostics.

R&D

Concept of AI overview of patient in clinical trial

How AI simulation could help de-risk obesity and cardiometab...

AI life sciences models allow researchers to explore different patient populations, protocols, and development strategies before a study starts.

Sales & Marketing

Accelerating growth through strategic investment in healthca...

CEVA FORPATIENTS at Rockingham, UK will offer the healthcare supply chain a new, sustainably designed multi-user site.

R&D

Alzheimer's research is moving toward more selective targets

As we mark World Alzheimer’s Day, it is worth reflecting on the progress made in recent years.

Articles

DTC budgets being trimmed substantially?

Rich Meyer questions whether DTC budgets are being substantially trimmed in the world of pharmaceutical marketing. A recent article about earnings for Pfizer indicated that “cost cutting” was a huge reason why the drug giant was improving its financial...

Articles

Patient perspectives: Elaine Schattner

We interview Elaine Schattner, breast cancer survivor, blogger and nonpracticing physician on what she thinks needs to change in order for patients’ needs to better be met. Elaine Schattner had severe scoliosis as a child and consequently spent a lot of time in doctors’ offices and hospital. She underwent...

Articles

Media perspectives: Rob Wright

Rob Wright, from Life Science Leader magazine, shares his unique perspective working within the media industry, after spending more than 17 years working in pharmaceuticals. Once a month we bring you a unique perspective on the media industry – this month it’s the turn of Rob Wright, Chief Editor...

Sales & Marketing

Accelerating growth through strategic investment in healthca...

CEVA FORPATIENTS at Rockingham, UK will offer the healthcare supply chain a new, sustainably designed multi-user site.

Sales & Marketing

The patient communication crisis pharma can no longer ignore

Industry's significant investments in patient engagement are only effective if patients trust the communication enough to answer in the first place.

Digital

Pharma brands face golden opportunity to extend supply chain...

People are ready for technology that verifies authenticity and provides helpful information directly from the medicinal product itself.

Digital

Changing Faces: Digital and supplier hires, August 2026

Digital health, clinical technology, contract services, and life sciences suppliers all saw notable leadership changes last month.

Market Access

$100 notes in pill bottle on aquamarine background with spilled pills

How new PBM transparency rules will alter drug pricing

The complex drug pricing ecosystem means all stakeholders are scrambling to understand how the new regulations and PBMs’ adjustments will impact them.

Market Access